Our Work
Real projects delivering measurable impact — from rare disease platforms to patient advocacy initiatives that transform care pathways.
Solutions that matter
From pediatric oncology platforms to rare disease education initiatives, we’ve delivered solutions that matter. Each project demonstrates our co-creation approach in action — bringing together patients, medical experts, and pharmaceutical partners to achieve results that transform care pathways and improve outcomes.
Recent Case Studies
HCP Engagement
Defined a governance and education framework to support the co-creation of high-quality education initiatives. Setup and moderation of steering committee and working groups, alignment with scientific chairs, and structured development of educational content, symposia support, and patient-facing materials.
The approach ensured scientific rigor, stakeholder alignment, and scalable implementation across international settings.
Asset Strategy
Strategic and operational support for global oncology leadership initiatives. Defined end-to-end project coordination, cross-functional alignment, risk and resource management, and performance monitoring to translate strategic priorities into executable programs. The framework ensured continuity, governance, and high-quality delivery across complex, multi-stakeholder oncology initiatives.
Patient & HCP Communication
A patient-centered digital care platform delivered end to end, from strategic direction to implementation and long-term operation. Our work covered platform strategy, project and stakeholder management, technical implementation, and continuous support to ensure adoption, scalability, and sustained value for patients, healthcare professionals, and partners across international settings, involving scientific study groups and international physician associations.
Oncology Masterclass
A 4-day event focused solely on our client. Disease arease covered included Acute Myeloid Leukemia, Pancreatic Cancer, Colorectal Cancer, Cholangiocracinoma and supportive care. Workshops and plenary sessions are presented to a select group of 300+ physicians. Our team managed circa 1200 slides, medical information development, design identity development, technical aspects and on-site logistics.
Advisory Boards
Advisory boards are an important component of the scientific development and understanding of pharmaceutical drugs. Our team assists in developing the discussion materials, including graphical representations, agendas and scientific drawings and diagrams. Custom interactivity can also be created to suit your needs. Our team then attends in person, manages the recording of the advisory board and later delivers a complete, sectioned report with insights from your advisory board.
Scientific Slide Deck Development
From mechanism of action designs to epidemiological data, our team can support a wide variety of detailed scientific and medical concepts. Recently, we completed a slide deck covering KMT2Ar and NPM1 Acute Myeloid Leukemia. This included mechanism of action designs, the epidemiology of the disease, an overview of current studies, available treatments and more- all tailored to the client’s specific needs. Other examples of our work include epidemiological research after the 2021 WHO Glioma re-classification, surgery options and incidence for low-grade glioma (LGG), and Non-small cell lung cancer (NSCLC) patient pathway visualization.